AstraZeneca's Lynparza meets main goal of late-stage cancer study

British drugmaker AstraZeneca Plc said on Tuesday its cancer drug being jointly developed with U.S.-based Merck& Co met the primary goal in a late-stage study for pancreatic cancer.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news